EXERTIONAL ANGINA has been explained on the basis of increased myocardial oxygen demand in the presence of fixed stenosis of coronary arteries.1 2 Thus, ,3-adrenergic-blocking drugs that decrease myocardial oxygen demand have been widely used in its treatment.2> Recently, acute reduction of myocardial blood flow or oxygen supply due to coronary artery spasm has been shown to play an important role in the pathogenesis of exercise-induced attack not only in patients with variant angina,5 but also in patients with classic exertional angina.8 In these patients, the drugs of choice for the treatment of exercise-induced attack would be calcium antagonists, which suppress coronary artery spasm, rather than ,3-adrenergic-blocking
drugs. However, the precise role of 8-adrenergicblocking drugs and/or calcium antagonists in the treatment of exercise-induced attack in patients with variant angina has not been defined. Exercise 201T1 myocardial scintigraphy provides quantitative information concerning the effective regional myocardial blood flow.9 '°In the present study, using exercise 201T1 myocardial scintigraphy, we examined the effects of propranolol, a f3-adrenergic blocker, and those of nifedipine, a calcium antagonist, on exercise-induced attack in patients with variant angina.
Methods
Patients. Twenty patients with variant angina were studied over 3 weeks during an active phase of their disease. All patients gave informed consent before they were included in the study. All patients had attacks of chest pain associated with ST segment elevation on the electrocardiogram (ECG). This pain occurred at rest, usually in the middle of the night or early moming, and more than five times per week during the period of the study. In all patients, coronary arteriography demonstrated coronary artery spasm during anginal attack. None of the pa-THERAPY AND PREVENTION-VARIANT ANGINA tients had prior myocardial infarction, heart failure, chronic obstructive lung disease, or other severe complications. A summary of clinical data, including age, sex, ECG during spontaneous attack, and exercise 20IT1 myocardial scintigraphic, and coronary arteriographic findings is shown in table 1.
Study protocol. Drug trials were performed by a single-blind placebo-controlled protocol. All medications were discontinued at least 3 days before the study except for nitroglycerin, which was also stopped at least 2 hr before the study. Each patient repeated the exercise test as described below at 8:30 to 9:30 A.M., 2 hr after oral administration of 80 mg propranolol, 20 mg nifedipine, or placebo. Each drug trial was performed singly on separate mornings with an intervening interval of more than 1 week. The sequence of the drug trials was randomized.
Exercise and scintigraphic procedure. It has been shown that anginal attack is most easily induced by the first exercise in the morning in patients with variant angina.5 Thus, the patients were kept in bed after an overnight fast until 8:00 to 9:00 A.M., and then they were taken to the exercise room in a wheelchair. Exercise was performed by upright subjects on an electrically graded bicycle ergometer starting at a workload of 50 W with increments of 25 W every 3 min. A 12-lead ECG and cuff blood pressure were recorded at rest, during exercise, and several minutes after exercise. All patients had undergone the same ergometer test at least once before the study so that they became familiar with the test procedure.
A bolus of 2. normal subjects. One of the maps depicts extent of count reduction and the other its severity. The extent polar map is a binary map on which points falling below the corresponding lower normal limits are shown as a black region and the remaining points fall in a white region. The severity polar map indicates the magnitude of count reduction at each point below the corresponding lower normal limits as a gray level varying between light gray (low grade) and black (high grade). On these two polar maps, each region of the left ventricle was positioned in the same way as on the two-dimensional polar map.
The extent and severity scores for the size of the perfusion defect were then calculated as described below, and the effects of propranolol and nifedipine on regional myocardial blood flow were quantitatively evaluated by comparing these scores in patients on drugs with scores of those on placebo. The In the 15 patients who had an exercise-induced attack during this study, peak heart rate and rate-pressure product on propranolol were both significantly less than those in patients on placebo (p < .001 and p < .01, respectively), indicating that myocardial oxygen demand at peak exercise was significantly decreased in those on propranolol. However, the exercise duration with propranolol was significantly shorter than that with placebo (p < .05). On the other hand, the exercise duration with nifedipine was significantly longer than that with placebo (p < .05). However, peak heart rate in patients on nifedipine was significantly higher than that of those on placebo ( APatient in whom exercise-induced attack did not occur during this study.
propranolol, and in none on nifedipine. The electrocardiographic leads showing ST segment elevation during exercise always corresponded with those during spontaneous attacks in these patients. The exercise-induced attacks accompanied by ST segment elevation were promptly relieved by sublingual nitroglycerin. Quantitative analysis of defect size (figure 1). Each patient experiencing an exercise-induced attack had a perfusion defect in the area possibly perfused by the coronary artery in which spasm was demonstrated by coronary arteriography during the attack. Among the 15 patients with an exercise-induced attack, the extent and the severity scores of patients on propranolol were significantly greater than those of patients on placebo (both p < .05). On the other hand, the extent and the severity scores of those on nifedipine were significantly less than the scores of those on placebo (both p < 376 .01). Representative examples are shown in figures 2 and 3.
Discussion
Propranolol is widely used for the treatment of classic exertional angina.2" However, Robertson et al. 13 showed that propranolol aggravated spontaneous attacks in patients with variant angina. Thus, the precise role of propranolol in the treatment of exercise-induced attack in patients with variant angina has not been defined.
In the present study, propranolol did not suppress but rather aggravated exercise-induced angina, decreasing the exercise duration in spite of the fact that it reduced peak rate-pressure product (an indirect index of myocardial oxygen demand). This aggravating effect might be explained by the increased size of the Each map is displayed as described in figure 2 . Note that the extent and severity of the perfusion defect in the inferoseptal left ventricular area were increased after propranolol, but markedly decreased after nifedipine, as compared with after placebo. The extent scores when the patient was on placebo, propranolol, and nifedipine were 16%, 43%, and 4%, respectively. The severity scores when the patient was on placebo, propranolol, nifedipine were 0.6, 2.6, and 0.05 counts/point, respectively. An attack was induced after placebo and propranolol, but not induced after nifedipine. The attack after propranolol was associated with ST segment depression, but the attack after placebo was not associated with ST segment deviation.
basis by platelets or thrombus might also be involved in the exercise-induced attacks accompanied by ST segment elevation cannot be excluded. However, this was not likely the case in this study because sublingual nitroglycerin promptly relieved the exercise-induced attacks and ST segment elevation in our patients with variant angina.
Clinical implications. Recent evidence suggests that coronary artery spasm may play an important role in the pathogenesis not only of variant angina but also of many clinical conditions related to ischemic heart disease. , 25 26 Propranolol, which is widely used in the treatment of exertional angina,24 may aggravate the attacks by reducing regional myocardial blood flow due to stress or exercise-induced coronary artery spasm in some patients with exertional angina. On the other hand, a calcium antagonist such as nifedipine would be the first choice of treatment for such patients.
Our results also indicate that exercise 20lT1 myocardial scintigraphy combined with the technique of single two-dimensional display of rotational tomogramsll 12 is useful in the noninvasive evaluation of the effects of antianginal drugs on regional myocardial perfusion in patients with variant angina.
